Inspire Medical Systems, Inc. released preliminary unaudited revenue results for Q4 2025 and full year 2025, showing strong growth.
The company anticipates revenue for Q4 2025 to be around $268.9 million to $269.1 million, a 12% increase over Q4 2024.
For full year 2025, revenue is expected to be in the range of $911.8 million to $912.0 million, a 14% increase over 2024.
Revenue Growth
Q4 2025 revenue up by 12% over Q4 2024; Full year 2025 revenue increased by 14% compared to 2024.
2026 Revenue Guidance
Anticipating a 10%-11% revenue increase for 2026 compared to 2025.
New CFO Appointment
Matt Osberg appointed as Executive VP and CFO, bringing over 20 years of financial leadership experience.
- The strong revenue performance in Q4 2025 showcases the company's execution and momentum.
- The launch of the Inspire V system in 2025 contributed to the significant growth observed throughout the year.
Inspire Medical Systems looks forward to continued growth in 2026, driven by the positive response to its latest product offerings and strategic financial leadership.